MannKind has initiated patient enrollment in two pivotal 12-month phase III clinical trials of its Technosphere Insulin in patients with type 1 and type 2 diabetes. MannKind is a diabetes and cancer treatment developer.
To evaluate the efficacy of...
More than 2 years with Instablogs, it has provided me with a global platform to ventilate my knowledge and views on environmental and health issues. Previous to this, I have been reporting health as a ‘Television Journalist’ for 3 years. Two years of ‘Teaching Journalism’ in undergraduate colleges have given me insight to what helped me as a professional.
Working with an NGO as a ‘Science and...